PTC Therapeutics(CH:P91)
CH:P91
PTC Therapeutics earnings date
PTC Therapeutics (P91) Q2 2018 Earnings Report
1 Followers
CH:P91 Q2 2018 EPS Results
- Actual EPS
- -CHF 0.17
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -CHF 0.36
CH:P91 Q2 2018 Revenue Results
- Actual Revenue
- CHF 56.35M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/07/2018
- Time
- After Close
- Conference Call
- Tuesday, August 7, 2018
CH:P91 Upcoming Earnings
PTC Therapeutics's next earnings date is estimated for February 23, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:P91 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 23, 2027 | 2026 (Q4) | 0.28- | -1.37 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.12-0.51 | 0.16 | -410.00% (-0.67) | |
| Jul 30, 2026 | 2026 (Q2) | 0.190.75 | -0.68 | 210.84% (+1.43) | |
| May 07, 2026 | 2026 (Q1) | -0.39-0.02 | 8.23 | -100.30% (-8.25) | |
| Feb 19, 2026 | 2025 (Q4) | 0.08-1.37 | -0.7 | -96.47% (-0.67) | |
| Nov 04, 2025 | 2025 (Q3) | -0.930.16 | -1.14 | 114.39% (+1.30) | |
| Aug 07, 2025 | 2025 (Q2) | -0.84-0.68 | -1.06 | 35.66% (+0.38) | |
| May 06, 2025 | 2025 (Q1) | -0.838.23 | -0.98 | 936.67% (+9.21) | |
| Feb 27, 2025 | 2024 (Q4) | -0.44-0.70 | -1.69 | 58.74% (+0.99) | |
| Nov 07, 2024 | 2024 (Q3) | -1.25-1.14 | -1.44 | 21.02% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
